The slip
PARKINSON RECEIPTno. 1701
18 Oct 2026, 04:29 UTCdopamine neurons, braak
predictionFFAR1 in dopamine neurons tracks Braak Lewy-body stage
registered408ca3c09170ec55
discovery-0.69 p=0.041 n=9
replication-0.50 p=0.166 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery -0.69 p 0.041; held-out -0.50 p 0.166)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATE30bb9a7253036329c88fa076…
follows 360f649c668b…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 1701: FFAR1 in dopamine neurons, braak
- power
- full sample -0.66 (p 0.0028, n 18), 95% CI -0.86 to -0.28. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.62 (p 0.0060, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.60 (p 0.0089, n 18). not the mix.
- skeptic
- leave-one-out range -0.75 to -0.62, sign flips 0; without severely affected donors -0.66 (p 0.0028, n 18). robust.
- cell type
- strongest in oligodendrocytes: -0.72 (p 7.4e-4, n 18) vs -0.66 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for FFAR1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up FFAR1 · oligodendrocytes · braak: substantia nigra, an independent cohort: not measured